October 15-17, 2013 – Business of
Biosimilars*** (Institute for
International Research) – Boston, MA

October 16, 2013 – Post-Grant
Review — Coming Soon (Intellectual Property Owners Association) – 2:00 to 3:00 pm
(ET)

October 22, 2013 – Patent 'Trolls' Under Fire: Strategies,
Tactics and Legislation Impacting University Patents & Licensing (Technology
Transfer Tactics) – 1:00 to 2:00 pm (Eastern)

October 22, 2013 – Reverse-Payment License Agreements: A Review
of the Hatch-Waxman Act Post-Actavis (American Bar
Association Section of Intellectual Property Law, Young Lawyers Division,
and Center for Professional Development) – 2:00 to 3:30 pm (Eastern)

October
23, 2013 – European biotech patent law update (D
Young & Co) – 4:00 am, 7:00 am, 12:00 pm (EDT)

October 24, 2013 – Divided Patent Infringement and Inducement:
Protecting IP Rights — Latest Strategies for Drafting and Prosecuting Claims
and Allocating Liability (Strafford) – 1:00 to 2:30 pm
(EDT)

October 29, 2013 – IP Due Diligence in M&A Transactions —
Conducting IP Investigations and Leveraging Results During Deal Negotiations (Strafford) – 1:00 to 2:30 pm (EDT)

October 29-30, 2013 – European Patent Practice Seminar (John Marshall Law
School Center for Intellectual Property Law & Kuhnen & Wacker) – Chicago, IL

October
31, 2013 – Strategic Use of Patent Reissue After the AIA
— Correcting Errors in Patents, Determining Whether and When to Pursue a
Reissue Application, and Mastering the Recapture Rule (Strafford) – 1:00 to 2:30 pm (EDT)

November 4-5, 2013 – FDA Boot Camp Devices Edition*** (American Conference
Institute) – Chicago, IL

November 4-5, 2013 – Trade Secrets: Protecting Your Intellectual Capital and Confidential
Business Information*** (American Conference
Institute) – Chicago, IL

November 6-8, 2013 – 2013 Fall Intellectual Property
Counsels Committee (IPCC) Conference (Biotechnology
Industry Organization) – Washington, DC

November 7, 2013 – On Sale and Public Use Bars to Patentability
After AIA — Minimizing the Risk of Patent Ineligibility or Invalidation (Strafford) – 1:00 to 2:30 pm (EDT)

November 8, 2013 – 5th
Annual RIPL Symposium (John Marshall
Law School Review of Intellectual Property Law (RIPL)) – Chicago, IL

November 14, 2013 – Obviousness Standard After the AIA:
Leveraging Latest PTO and Court Guidance — Overcoming Challenges of
Obviousness and Attacks on Patent Validity (Strafford) – 1:00 to 2:30 pm (EDT)

November 17-20, 2013 – Creating and Leveraging Intellectual Property in Developing Countries: A Power Tool for Social and
Economic Growth*** (Companies and IP Commission and National
IP Management Office of South Africa) – Durban, South Africa

November
19, 2013 – PTAB or the District Court: Which
Is the Better Option When Challenging Patent Validity? (McDonnell
Boehnen Hulbert & Berghoff LLP) – 10:00 to 11:15 am (CT)

November
19, 2013 – Patenting Biotech Inventions (California
Healthcare Institute (CHI) and D Young & Co) – San Diego, CA

November 20, 2013 – Patenting Biotech Inventions (California
Healthcare Institute (CHI) and D Young & Co) – San Francisco, CA

December 9-10, 2013 – Patent Infringement Litigation Summit (Legal iQ (IQPC)) – San Francisco, CA

December 10-11, 2013 – Advanced
Forum on Patent Litigation*** (American Conference
Institute) – New York, NY

***Patent Docs is a media partner of this conference or CLE